Prescribing practices for the management of headache in Newfoundland and Labrador

Headache

Volumn 36, Issue 9, 1996, Pages 542-546

  Furlong, Stephen ^a   Pryse Phillips, William ^a   Crowley, Mary ^b   Turner, Christopher J ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b Government of Newfoundland and Labrador   (Canada)

Author keywords

analgesic rebound headache; migraine; prescribing practices; sumatriptan

Indexed keywords

ACETYLSALICYLIC ACID; AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ATENOLOL; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAFFEINE; CALCIUM CHANNEL BLOCKING AGENT; CIMETIDINE; CODEINE; DEXTROPROPOXYPHENE; DICLOFENAC; ERGOTAMINE; ESTROGEN; FLUNARIZINE; HISTAMINE H2 RECEPTOR ANTAGONIST; INDOMETACIN; MUSCLE RELAXANT AGENT; NARCOTIC ANALGESIC AGENT; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PETHIDINE; RANITIDINE; SEDATIVE AGENT; SEROTONIN ANTAGONIST; SUMATRIPTAN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; HEADACHE; HUMAN; MEDICAL RECORD; MIGRAINE; PRESCRIPTION; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY;

ANALGESICS; COHORT STUDIES; HEADACHE; HUMANS; MIGRAINE DISORDERS; NEWFOUNDLAND; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; SEROTONIN AGONISTS; SUMATRIPTAN; TREATMENT OUTCOME;

EID: 0029911841     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1996.3609542.x     Document Type: Article

References (13)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7): 10-73.
2. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol. 1982;33:335-341.
3. Rapoport AM. Analgesic rebound headache. Headache. 1988;28:662-665.
4. Mathew NT. Drug-induced headache. Neurol Clin. 1990;8:903-912.
5. MacGregor EA, Vohrah C, Wilkinson M. Analgesic use: a study of treatments used by patients for migraine prior to attending the City of London Migraine Clinic. Headache. 1990;30:571-574.
6. Edmeads J. Analgesic-induced headaches: an unrecognized epidemic. Headache. 1990;30:614-615.
7. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache. 1987;27:102-106.
8. Diamond S, Dalessio DJ. Drug abuse in headache. In: Diamond S, Dalessio DJ, eds. The Practicing Physician's Approach to Headache. Baltimore: Williams & Wilkins; 1986:192-199.
9. Hering R, Steiner TJ. Abrupt outpatient withdrawal of medication in analgesic-abusing migraineurs. Lancet. 1991;337:1442-1443.
10. Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache. 1990;30:334-339.
11. Raskin NH. Modern pharmacotherapy of migraine. Neurol Clin. 1990;8:857-865.
12. Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology. 1986;36:995-997.
13. Askmark H, Lundberg PO, Olsson S. Drug-related headache. Headache. 1989;29:441-444.